nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—type 2 diabetes mellitus—polycystic ovary syndrome	0.958	1	CtDrD
Glimepiride—Reaction gastrointestinal—Metformin—polycystic ovary syndrome	0.00357	0.135	CcSEcCtD
Glimepiride—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.00203	0.0768	CcSEcCtD
Glimepiride—ABCC8—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.00146	0.11	CbGpPWpGaD
Glimepiride—Accidental injury—Metformin—polycystic ovary syndrome	0.00135	0.051	CcSEcCtD
Glimepiride—KCNJ11—Type II diabetes mellitus—INS-IGF2—polycystic ovary syndrome	0.0012	0.0907	CbGpPWpGaD
Glimepiride—Gliclazide—VEGFA—polycystic ovary syndrome	0.00111	0.565	CrCbGaD
Glimepiride—Injury—Metformin—polycystic ovary syndrome	0.000941	0.0357	CcSEcCtD
Glimepiride—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000886	0.0336	CcSEcCtD
Glimepiride—Pain in extremity—Metformin—polycystic ovary syndrome	0.000865	0.0328	CcSEcCtD
Glimepiride—Glipizide—PPARG—polycystic ovary syndrome	0.000851	0.435	CrCbGaD
Glimepiride—Abdominal distension—Metformin—polycystic ovary syndrome	0.000753	0.0285	CcSEcCtD
Glimepiride—Influenza—Metformin—polycystic ovary syndrome	0.000748	0.0283	CcSEcCtD
Glimepiride—Sweating increased—Metformin—polycystic ovary syndrome	0.000728	0.0276	CcSEcCtD
Glimepiride—Angina pectoris—Metformin—polycystic ovary syndrome	0.000728	0.0276	CcSEcCtD
Glimepiride—Drowsiness—Metformin—polycystic ovary syndrome	0.000667	0.0253	CcSEcCtD
Glimepiride—Bradycardia—Metformin—polycystic ovary syndrome	0.000609	0.0231	CcSEcCtD
Glimepiride—KCNJ11—Type II diabetes mellitus—INSR—polycystic ovary syndrome	0.000609	0.0459	CbGpPWpGaD
Glimepiride—Hepatitis—Metformin—polycystic ovary syndrome	0.000598	0.0227	CcSEcCtD
Glimepiride—Malnutrition—Metformin—polycystic ovary syndrome	0.000521	0.0197	CcSEcCtD
Glimepiride—Erythema—Metformin—polycystic ovary syndrome	0.000521	0.0197	CcSEcCtD
Glimepiride—KCNJ11—Type II diabetes mellitus—ADIPOQ—polycystic ovary syndrome	0.000508	0.0382	CbGpPWpGaD
Glimepiride—Vision blurred—Metformin—polycystic ovary syndrome	0.000491	0.0186	CcSEcCtD
Glimepiride—Tremor—Metformin—polycystic ovary syndrome	0.000488	0.0185	CcSEcCtD
Glimepiride—KCNJ11—Type II diabetes mellitus—SLC2A4—polycystic ovary syndrome	0.000479	0.0361	CbGpPWpGaD
Glimepiride—Palpitations—Metformin—polycystic ovary syndrome	0.00046	0.0174	CcSEcCtD
Glimepiride—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000458	0.0173	CcSEcCtD
Glimepiride—Hypertension—Metformin—polycystic ovary syndrome	0.00045	0.017	CcSEcCtD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.00042	0.0317	CbGpPWpGaD
Glimepiride—Shock—Metformin—polycystic ovary syndrome	0.000418	0.0158	CcSEcCtD
Glimepiride—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000416	0.0158	CcSEcCtD
Glimepiride—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000411	0.0156	CcSEcCtD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.000408	0.0307	CbGpPWpGaD
Glimepiride—Anorexia—Metformin—polycystic ovary syndrome	0.000405	0.0154	CcSEcCtD
Glimepiride—Hypotension—Metformin—polycystic ovary syndrome	0.000397	0.0151	CcSEcCtD
Glimepiride—Paraesthesia—Metformin—polycystic ovary syndrome	0.000382	0.0145	CcSEcCtD
Glimepiride—Dyspnoea—Metformin—polycystic ovary syndrome	0.000379	0.0144	CcSEcCtD
Glimepiride—Somnolence—Metformin—polycystic ovary syndrome	0.000378	0.0143	CcSEcCtD
Glimepiride—Dyspepsia—Metformin—polycystic ovary syndrome	0.000374	0.0142	CcSEcCtD
Glimepiride—Decreased appetite—Metformin—polycystic ovary syndrome	0.00037	0.014	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000367	0.0139	CcSEcCtD
Glimepiride—Fatigue—Metformin—polycystic ovary syndrome	0.000367	0.0139	CcSEcCtD
Glimepiride—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00035	0.0133	CcSEcCtD
Glimepiride—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000348	0.0132	CcSEcCtD
Glimepiride—Urticaria—Metformin—polycystic ovary syndrome	0.000338	0.0128	CcSEcCtD
Glimepiride—Abdominal pain—Metformin—polycystic ovary syndrome	0.000336	0.0127	CcSEcCtD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.000334	0.0252	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.000324	0.0244	CbGpPWpGaD
Glimepiride—Asthenia—Metformin—polycystic ovary syndrome	0.000305	0.0116	CcSEcCtD
Glimepiride—Pruritus—Metformin—polycystic ovary syndrome	0.000301	0.0114	CcSEcCtD
Glimepiride—Diarrhoea—Metformin—polycystic ovary syndrome	0.000291	0.011	CcSEcCtD
Glimepiride—KCNJ11—Type II diabetes mellitus—IRS1—polycystic ovary syndrome	0.000281	0.0212	CbGpPWpGaD
Glimepiride—Dizziness—Metformin—polycystic ovary syndrome	0.000281	0.0107	CcSEcCtD
Glimepiride—Vomiting—Metformin—polycystic ovary syndrome	0.00027	0.0102	CcSEcCtD
Glimepiride—Rash—Metformin—polycystic ovary syndrome	0.000268	0.0102	CcSEcCtD
Glimepiride—Dermatitis—Metformin—polycystic ovary syndrome	0.000268	0.0101	CcSEcCtD
Glimepiride—Headache—Metformin—polycystic ovary syndrome	0.000266	0.0101	CcSEcCtD
Glimepiride—Nausea—Metformin—polycystic ovary syndrome	0.000253	0.00957	CcSEcCtD
Glimepiride—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.000222	0.0167	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—NR3C1—polycystic ovary syndrome	0.00021	0.0158	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NR3C1—polycystic ovary syndrome	0.000204	0.0153	CbGpPWpGaD
Glimepiride—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.000202	0.0152	CbGpPWpGaD
Glimepiride—CYP2C9—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000195	0.0147	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.00016	0.012	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.000155	0.0117	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000153	0.0115	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000152	0.0115	CbGpPWpGaD
Glimepiride—ABCC8—Regulation of insulin secretion—GNAS—polycystic ovary syndrome	0.000152	0.0115	CbGpPWpGaD
Glimepiride—KCNJ11—Regulation of insulin secretion—GNAS—polycystic ovary syndrome	0.000148	0.0111	CbGpPWpGaD
Glimepiride—CYP2C9—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000139	0.0105	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—DLG4—polycystic ovary syndrome	0.000135	0.0102	CbGpPWpGaD
Glimepiride—ABCC8—Integration of energy metabolism—GNAS—polycystic ovary syndrome	0.00012	0.00902	CbGpPWpGaD
Glimepiride—KCNJ11—Integration of energy metabolism—GNAS—polycystic ovary syndrome	0.000116	0.00874	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000109	0.00818	CbGpPWpGaD
Glimepiride—CYP2C9—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000107	0.00804	CbGpPWpGaD
Glimepiride—CYP2C9—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000103	0.00773	CbGpPWpGaD
Glimepiride—ABCC8—Regulation of insulin secretion—INS—polycystic ovary syndrome	0.000102	0.00768	CbGpPWpGaD
Glimepiride—KCNJ11—Regulation of insulin secretion—INS—polycystic ovary syndrome	9.89e-05	0.00745	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	9.82e-05	0.00739	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	8.16e-05	0.00615	CbGpPWpGaD
Glimepiride—ABCC8—Integration of energy metabolism—INS—polycystic ovary syndrome	8.02e-05	0.00604	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—CAMK2D—polycystic ovary syndrome	7.82e-05	0.00589	CbGpPWpGaD
Glimepiride—KCNJ11—Integration of energy metabolism—INS—polycystic ovary syndrome	7.77e-05	0.00586	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—CAMK2D—polycystic ovary syndrome	7.58e-05	0.00571	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	7.47e-05	0.00563	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	7.37e-05	0.00555	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	7e-05	0.00527	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	6.95e-05	0.00523	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—DLG4—polycystic ovary syndrome	6.91e-05	0.00521	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	6.85e-05	0.00516	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—DLG4—polycystic ovary syndrome	6.7e-05	0.00505	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NMNAT3—polycystic ovary syndrome	6.36e-05	0.00479	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NMNAT3—polycystic ovary syndrome	6.17e-05	0.00464	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	6.06e-05	0.00456	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SUOX—polycystic ovary syndrome	5.82e-05	0.00438	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LPCAT2—polycystic ovary syndrome	5.82e-05	0.00438	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LPCAT2—polycystic ovary syndrome	5.64e-05	0.00425	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SUOX—polycystic ovary syndrome	5.64e-05	0.00425	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	5.63e-05	0.00424	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	5.5e-05	0.00414	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	5.42e-05	0.00409	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ISYNA1—polycystic ovary syndrome	5.41e-05	0.00407	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	5.28e-05	0.00397	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ISYNA1—polycystic ovary syndrome	5.24e-05	0.00395	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	5.13e-05	0.00386	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—TEAD2—polycystic ovary syndrome	4.6e-05	0.00346	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKR1C2—polycystic ovary syndrome	4.6e-05	0.00346	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKR1C2—polycystic ovary syndrome	4.46e-05	0.00336	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—TEAD2—polycystic ovary syndrome	4.46e-05	0.00336	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	4.46e-05	0.00336	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	4.43e-05	0.00334	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	4.37e-05	0.00329	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.1e-05	0.00309	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	3.89e-05	0.00293	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PNPLA2—polycystic ovary syndrome	3.85e-05	0.0029	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.81e-05	0.00287	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PNPLA2—polycystic ovary syndrome	3.74e-05	0.00281	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SRD5A1—polycystic ovary syndrome	3.65e-05	0.00275	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	3.63e-05	0.00274	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	3.59e-05	0.00271	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	3.58e-05	0.0027	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SRD5A1—polycystic ovary syndrome	3.54e-05	0.00267	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—STAR—polycystic ovary syndrome	3.48e-05	0.00262	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.48e-05	0.00262	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	3.45e-05	0.0026	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—STAR—polycystic ovary syndrome	3.38e-05	0.00254	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	3.3e-05	0.00249	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	3.22e-05	0.00242	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	3.17e-05	0.00239	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HMMR—polycystic ovary syndrome	3.11e-05	0.00234	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HMMR—polycystic ovary syndrome	3.01e-05	0.00227	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	3e-05	0.00226	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	2.99e-05	0.00225	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HSD3B1—polycystic ovary syndrome	2.96e-05	0.00223	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	2.95e-05	0.00222	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.92e-05	0.0022	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HSD3B1—polycystic ovary syndrome	2.87e-05	0.00216	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	2.72e-05	0.00205	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	2.72e-05	0.00205	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LHB—polycystic ovary syndrome	2.7e-05	0.00204	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	2.68e-05	0.00202	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HSD3B2—polycystic ovary syndrome	2.64e-05	0.00199	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LHB—polycystic ovary syndrome	2.62e-05	0.00197	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HSD3B2—polycystic ovary syndrome	2.56e-05	0.00193	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKR1C1—polycystic ovary syndrome	2.56e-05	0.00193	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKR1C1—polycystic ovary syndrome	2.48e-05	0.00187	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.37e-05	0.00178	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SULT2A1—polycystic ovary syndrome	2.35e-05	0.00177	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.33e-05	0.00176	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	2.28e-05	0.00172	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SULT2A1—polycystic ovary syndrome	2.28e-05	0.00172	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—RRM2—polycystic ovary syndrome	2.28e-05	0.00172	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—RRM2—polycystic ovary syndrome	2.21e-05	0.00166	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—YAP1—polycystic ovary syndrome	2.2e-05	0.00166	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	2.16e-05	0.00163	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—YAP1—polycystic ovary syndrome	2.13e-05	0.0016	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NAMPT—polycystic ovary syndrome	2.11e-05	0.00159	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP11A1—polycystic ovary syndrome	2.08e-05	0.00157	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	2.06e-05	0.00156	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NAMPT—polycystic ovary syndrome	2.05e-05	0.00154	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP11A1—polycystic ovary syndrome	2.02e-05	0.00152	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKR1C3—polycystic ovary syndrome	1.97e-05	0.00148	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP17A1—polycystic ovary syndrome	1.94e-05	0.00146	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKR1C3—polycystic ovary syndrome	1.91e-05	0.00144	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.91e-05	0.00144	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.88e-05	0.00142	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP17A1—polycystic ovary syndrome	1.88e-05	0.00142	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	1.76e-05	0.00132	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	1.68e-05	0.00126	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—TH—polycystic ovary syndrome	1.68e-05	0.00126	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC2A4—polycystic ovary syndrome	1.63e-05	0.00123	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—TH—polycystic ovary syndrome	1.63e-05	0.00122	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	1.6e-05	0.00121	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC2A4—polycystic ovary syndrome	1.58e-05	0.00119	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	1.56e-05	0.00118	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	1.54e-05	0.00116	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	1.54e-05	0.00116	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP19A1—polycystic ovary syndrome	1.53e-05	0.00116	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	1.52e-05	0.00114	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP19A1—polycystic ovary syndrome	1.49e-05	0.00112	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	1.43e-05	0.00107	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	1.42e-05	0.00107	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.39e-05	0.00105	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GNAS—polycystic ovary syndrome	1.37e-05	0.00103	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GNAS—polycystic ovary syndrome	1.33e-05	0.001	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NCOR1—polycystic ovary syndrome	1.3e-05	0.000982	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.3e-05	0.000981	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NCOR1—polycystic ovary syndrome	1.26e-05	0.000953	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP1A1—polycystic ovary syndrome	1.24e-05	0.000931	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.24e-05	0.000931	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	1.21e-05	0.000914	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	1.21e-05	0.000914	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP1A1—polycystic ovary syndrome	1.2e-05	0.000903	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.17e-05	0.000879	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTHFR—polycystic ovary syndrome	1.15e-05	0.000868	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.15e-05	0.000865	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTHFR—polycystic ovary syndrome	1.12e-05	0.000842	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	1.02e-05	0.000766	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	9.64e-06	0.000726	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPARG—polycystic ovary syndrome	9.35e-06	0.000704	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—POMC—polycystic ovary syndrome	9.22e-06	0.000694	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	9.2e-06	0.000693	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—INS—polycystic ovary syndrome	9.17e-06	0.00069	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.09e-06	0.000685	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPARG—polycystic ovary syndrome	9.06e-06	0.000683	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—POMC—polycystic ovary syndrome	8.94e-06	0.000673	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—INS—polycystic ovary syndrome	8.89e-06	0.00067	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	8.2e-06	0.000617	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	7.82e-06	0.000589	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.73e-06	0.000582	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.33e-06	0.000552	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	7.13e-06	0.000537	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	6.97e-06	0.000525	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	6.75e-06	0.000508	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	6.21e-06	0.000468	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	6.02e-06	0.000453	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	5.8e-06	0.000437	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	5.57e-06	0.00042	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.54e-06	0.000417	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.5e-06	0.000414	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.46e-06	0.000411	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	5.2e-06	0.000391	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.12e-06	0.000385	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.43e-06	0.000333	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.31e-06	0.000324	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4.05e-06	0.000305	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.61e-06	0.000272	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.44e-06	0.000259	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.26e-06	0.000246	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.04e-06	0.000229	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.47e-06	0.000186	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.43e-06	0.000183	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.42e-06	0.000182	CbGpPWpGaD
